World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN (O) : 2455-3301
ISSN (P) : 3051-2557
IMPACT FACTOR: 7.533

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

Abstract

RHUPUS: CLINICAL ANALYSIS OF A NEWLY REPORTED CASE

Boumaiz Firdaous, MD*, Zniber Amal, PhD, Benamar Loubna, PhD, Ouzeddoun Naima, PhD

ABSTRACT

Rhupus syndrome is a rare clinical c ondition characterized by the coexistence of rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), presenting unique diagnostic and therapeutic challenges in the field of rheumatology. This article details the clinical presentation, diagnostic criteria, and management of a newly identified case of Rhupus syndrome with significant renal involvement. We describe the case of a 25 year old North African woman with a complex medical history, who presented with symptoms indicative of both RA and SLE, including inflammatory polyarthralgia, facial erythema, and nephrotic syndrome. Comprehensive laboratory investigations, imaging studies, and a renal biopsy confirmed the diagnosis. The patient was treated with a combination of corticosteroids, cyclophosph amide, hydroxychloroquine, and azathioprine, leading to significant clinical improvement. This case highlights the importance of recognizing Rhupus syndrome as a distinct overlap syndrome and underscores the need for tailored therapeutic approaches to mana ge the complexities associated with simultaneous RA and SLE. Continued research is essential to further elucidate the pathogenesis of Rhupus syndrome and optimize treatment strategies for affected patients.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR